IL17A and systemic lupus erythematosus: Early reduction of circulating bacterial DNA by vancomycin treatment significantly decreased the percentage of Breg cells in the spleen, resulting in higher levels of IFNγ production, IL-17 mRNA expression, earlier disease initiation, and exacerbation of lupus.